(Q51733686)

English

Specificity concerns with antibodies for receptor mapping.

scientific article published in April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19348032

Specificity concerns with antibodies for receptor mapping. (English)

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19348032

1 reference

based on heuristic

inferred from title

author name string

Peter Kirkpatrick

1

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19348032

publication date

1 April 2009

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19348032

Nature Reviews Drug Discovery

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19348032

8

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19348032

4

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19348032

278

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19348032

https://scigraph.springernature.com/pub.10.1038/nrd2854

0 references

Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FNRD2854

31 March 2020

Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRD2854

31 March 2020

Lack of specificity of antibodies directed against human beta-adrenergic receptors.

1 reference

https://api.crossref.org/works/10.1038%2FNRD2854

31 March 2020

Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific

1 reference

https://api.crossref.org/works/10.1038%2FNRD2854

31 March 2020

Should we be cautious on the use of commercially available antibodies to dopamine receptors?

1 reference

https://api.crossref.org/works/10.1038%2FNRD2854

31 March 2020

Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FNRD2854

31 March 2020

Where is TRPV1 expressed in the bladder, do we see the real channel?

1 reference

https://api.crossref.org/works/10.1038%2FNRD2854

31 March 2020

Identifiers

10.1038/NRD2854

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19348032

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/19348032

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51733686&oldid=1366316909"